These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8380522)

  • 21. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 24. The neuromythology of Parkinson's Disease.
    Calne DB; Mizuno Y
    Parkinsonism Relat Disord; 2004 Jul; 10(5):319-22. PubMed ID: 15196512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial energy crisis in Parkinson's disease.
    Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
    Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
    [No Abstract]   [Full Text] [Related]  

  • 26. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The coenzyme Q10 status of the brain regions of Parkinson's disease patients.
    Hargreaves IP; Lane A; Sleiman PM
    Neurosci Lett; 2008 Dec; 447(1):17-9. PubMed ID: 18840506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease.
    Shergill JK; Cammack R; Cooper CE; Cooper JM; Mann VM; Schapira AH
    Biochem Biophys Res Commun; 1996 Nov; 228(2):298-305. PubMed ID: 8920909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts.
    Procaccio V; Mousson B; Beugnot R; Duborjal H; Feillet F; Putet G; Pignot-Paintrand I; Lombès A; De Coo R; Smeets H; Lunardi J; Issartel JP
    J Clin Invest; 1999 Jul; 104(1):83-92. PubMed ID: 10393702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidative mechanisms in nigral cell death in Parkinson's disease.
    Jenner P
    Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of NADH-oxidation in complex I and complex III deficient fibroblasts by menadione.
    Wijburg FA; de Groot CJ; Feller N; Wanders RJ
    J Inherit Metab Dis; 1991; 14(3):293-6. PubMed ID: 1663191
    [No Abstract]   [Full Text] [Related]  

  • 34. Degeneration of the centré median-parafascicular complex in Parkinson's disease.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Ann Neurol; 2000 Mar; 47(3):345-52. PubMed ID: 10716254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease.
    Attems J; Jellinger KA
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):466-7. PubMed ID: 18282157
    [No Abstract]   [Full Text] [Related]  

  • 36. Mitochondrial respiratory chain function in multiple system atrophy.
    Gu M; Gash MT; Cooper JM; Wenning GK; Daniel SE; Quinn NP; Marsden CD; Schapira AH
    Mov Disord; 1997 May; 12(3):418-22. PubMed ID: 9159739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 38. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
    Dexter DT; Sian J; Jenner P; Marsden CD
    Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet mitochondrial DNA in Parkinson's disease.
    Schapira AH; Marsden CD
    Mov Disord; 1994 Jan; 9(1):119-21. PubMed ID: 8139599
    [No Abstract]   [Full Text] [Related]  

  • 40. An abortive from of Parkinson's disease?
    Hubert JW; van Rossum JO
    Psychiatr Neurol Neurochir; 1969; 72(6):525-31. PubMed ID: 5369243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.